Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Shares Outstanding (Diluted Average): 2023-2025

Historic Shares Outstanding (Diluted Average) for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to $50.4 million.

  • Immunocore Holdings' Shares Outstanding (Diluted Average) fell 4.55% to $50.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.4 million, marking a year-over-year decrease of 4.55%. This contributed to the annual value of $50.0 million for FY2024, which is 2.25% up from last year.
  • As of Q3 2025, Immunocore Holdings' Shares Outstanding (Diluted Average) stood at $50.4 million, which was up 0.22% from $50.3 million recorded in Q2 2025.
  • Immunocore Holdings' Shares Outstanding (Diluted Average)'s 5-year high stood at $52.8 million during Q3 2024, with a 5-year trough of $48.9 million in Q4 2023.
  • For the 3-year period, Immunocore Holdings' Shares Outstanding (Diluted Average) averaged around $50.5 million, with its median value being $50.2 million (2024).
  • Over the last 5 years, Immunocore Holdings' Shares Outstanding (Diluted Average) had its largest YoY gain of 4.16% in 2025, and its largest YoY loss of 4.55% in 2025.
  • Over the past 3 years, Immunocore Holdings' Shares Outstanding (Diluted Average) (Quarterly) stood at $48.9 million in 2023, then climbed by 2.25% to $50.0 million in 2024, then decreased by 4.55% to $50.4 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $50.4 million in Q3 2025, compared to $50.3 million in Q2 2025 and $51.9 million in Q1 2025.